Report
Onward Medical NV - EUR 20m raise to bring neurostimulation technologies closer to patients
• This morning, ONWD announced a successful EUR 20m capital raise through an ABB, with significant participation from (existing) specialist healthcare investors globally, and separate retail offering in France• Majority of proceeds (60%) will be used for R&D purposes and ARC-EX launch preparation• Buy rating reiterated. We will update our estimates following this update and come back with an update shortly
Underlying
ONWARD MEDICAL NV
Provider
Degroof Petercam
We are an investment house with Belgian roots founded on more than 150 years of trust.
As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.
David Seynnaeve, PhD
Other Reports on these Companies
Other Reports from Degroof Petercam
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.